Table 3.
PD-1 inhibitor
|
CR
|
PR
|
SD
|
PD
|
P value
|
Tislelizumab | 2 (14.3) | 5 (35.7) | 4 (28.6) | 3 (24.1) | 0.927 |
Sintilimab | 1 (5.9) | 10 (58.8) | 5 (29.4) | 1 (5.9) | |
Camrelizumab | 6 (13.3) | 17 (37.8) | 14 (31.1) | 8 (17.8) | |
Toripalimab | 4 (14.3) | 12 (42.9) | 8 (28.5) | 4 (14.3) |
PD-1: Programmed cell death 1; CR: Complete response; PR: Partial response; SD: Stable disease; PD: Progressive disease.